Leucine
Key facts at a glance
- ATC
- B05BA01
- RxNorm
- 6218
- Generic
- Leucine
- Class
- unclassified
- Brands
- Freamine III 10, Clinimix E 4.25/10, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Trophamine 10 %, Trophamine 6 %, Plenamine, Prosol, PremaSol, Aminosyn II 15%, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn II 10 %, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Clinimix E 4.25/5
- Availability
- otc
- Pregnancy
- C
- Lactation
- caution
- Half-life (h)
- 2
- Onset (min)
- 0
- Duration (h)
- 0
- Routes
- intravenous, oral
- Forms
- injection solution, oral powder, capsules, tablets
- Regions
- United States, Canada, European Union, Australia, Japan
- Monitoring
- serum electrolytes, liver function tests, renal function, blood glucose, plasma amino acid levels, fluid status
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy